Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David W Mullins

Pilot Clinical Trials Testing the Safety and Effects on the Metastatic Melanoma Microenvironment of Intratumoral Interferon-Gamma or Imiquimod, Plus a Multipeptide Melanoma Vaccine

Journal for ImmunoTherapy of Cancer

English

Related publications

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells

International Journal of Cancer

Cancer Research

Oncology

2018

English

Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial

Journal of Interferon and Cytokine Research

English

Combined Targeted Therapy and Immunotherapy in Melanoma: A Review of the Impact on the Tumor Microenvironment and Outcomes of Early Clinical Trials

Therapeutic Advances in Medical Oncology

Oncology

2019

English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research

Cancer Research

Immunology

2014

English

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Clinical Cancer Research

Cancer Research

Oncology

2011

English

Prediction of Metastatic Melanoma in Nonsentinel Nodes and Clinical Outcome Based on the Primary Melanoma and the Sentinel Node

English

Analysis of DNA Methylation Patterns in the Tumor Immune Microenvironment of Metastatic Melanoma

English

Intratumoral Delivery of Tavokinogene Telseplasmid Yields Systemic Immune Responses in Metastatic Melanoma Patients

English

813 Melanoma Exosomes Mediates the Dysfunction of Interferon Signaling Pathway in Lymphocytes in Tumor Microenvironment

Journal of Investigative Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David W Mullins

Pilot Clinical Trials Testing the Safety and Effects on the Metastatic Melanoma Microenvironment of Intratumoral Interferon-Gamma or Imiquimod, Plus a Multipeptide Melanoma Vaccine

Related publications

The Metastatic Microenvironment: Melanoma-Microglia Cross-Talk Promotes the Malignant Phenotype of Melanoma Cells

Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial

Combined Targeted Therapy and Immunotherapy in Melanoma: A Review of the Impact on the Tumor Microenvironment and Outcomes of Early Clinical Trials

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Molecular Insights on the Peripheral and Intratumoral Effects of Systemic High-Dose rIL-2 (Aldesleukin) Administration for the Treatment of Metastatic Melanoma

Prediction of Metastatic Melanoma in Nonsentinel Nodes and Clinical Outcome Based on the Primary Melanoma and the Sentinel Node

Analysis of DNA Methylation Patterns in the Tumor Immune Microenvironment of Metastatic Melanoma

Intratumoral Delivery of Tavokinogene Telseplasmid Yields Systemic Immune Responses in Metastatic Melanoma Patients

813 Melanoma Exosomes Mediates the Dysfunction of Interferon Signaling Pathway in Lymphocytes in Tumor Microenvironment